Market Place
Sourcing Support
PharmaJet® Delivery Systems Show Efficacy in mRNA Vaccine Delivery
12 Nov 2024 //
BUSINESSWIRE
PharmaJet Needle-free Tech Highlighted at Cancer Immunotherapy
05 Nov 2024 //
BUSINESSWIRE
PharmaJet Announces Study Results For Tropis Needle-free Delivery
24 Oct 2024 //
BUSINESSWIRE
PharmaJet Presents On Vaccine Performance At World Vaccine Congress
17 Oct 2024 //
BUSINESSWIRE
PharmaJet Needle-free System Selected for WHO Polio Immunization Campaign
27 Jun 2024 //
BUSINESSWIRE
PharmaJet Announces Scientific Advisory Boards and Presentation at WVC
01 Apr 2024 //
BUSINESSWIRE
PharmaJet Begin Implementation of Study Using Tropis ID for Routine Immunization
24 Oct 2023 //
BUSINESSWIRE
PharmaJet Partner, Scancell, Announces Positive Data from Phase 2 Trial
28 Sep 2023 //
BUSINESSWIRE
Nanette Cocero Joins the PharmaJet Board of Directors
11 Jul 2023 //
BUSINESSWIRE
Marie Mazur Appointed Chair of PharmaJet Board of Directors
06 Jun 2023 //
BUSINESSWIRE
WHO initiates polio eradication campaign in Pakistan using needle-free syringes
24 May 2023 //
BIOSPECTRUM ASIA
PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA
18 Apr 2023 //
BUSINESSWIRE
PharmaJet Partner Gennova Seeks EUA for the First Needle-Free mRNA Vaccine
03 Apr 2023 //
BUSINESSWIRE
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study
21 Mar 2023 //
BUSINESSWIRE
Review Highlights Growing Evidence That PharmaJet’s Precision
23 Feb 2023 //
BUSINESSWIRE
PharmaJet Partner Immunomic Receive FDA Fast Track Designation for pDNA Vaccine
13 Dec 2022 //
BUSINESSWIRE
PharmaJet Receive NIH Grant to Evaluate use of Needle-free Intradermal Delivery
29 Nov 2022 //
BUSINESSWIRE
PharmaJet partners to use needle-free tech in polio vaccine push
15 Nov 2022 //
FIERCEPHARMA
PharmaJet Announces $1.5 million Grant From USAID
24 Oct 2022 //
BUSINESSWIRE
PharmaJet to Present Latest Research Showing Superior Immunogenicity
27 Sep 2022 //
BUSINESSWIRE
PharmaJet Shows Benefits of Needle-free at Military Health Research Symposium
12 Sep 2022 //
BUSINESSWIRE
WHO selects PharmaJet Needle-free Injection System for Vaccination Campaign
31 Aug 2022 //
BUSINESSWIRE
University of Adelaide Begins Human Trial of Omicron COVID Vaccine Booster
16 Aug 2022 //
BUSINESSWIRE
Scancell`s PII Melanoma DNA Vaccine Trial will include Needle-free Delivery
02 Aug 2022 //
BUSINESSWIRE
PharmaJet: Benefits of Needle-free at mRNA-Based Therapeutics Summit
19 Jul 2022 //
BUSINESSWIRE
PharmaJet Presents Multiple Partners’ Data Demonstrating Superior Immunogenicity
05 Jul 2022 //
BUSINESSWIRE
Nykode Therapeutics Announces Positive Interim Results in PII Trial
21 Jun 2022 //
BUSINESSWIRE
Institute for Molecular Medicine, Launches Trial for Alzheimer’s DNA Vaccine
24 May 2022 //
BUSINESSWIRE
PharmaJet Announces Addition of Darin Zehrung as CBDO
10 May 2022 //
BUSINESSWIRE
PharmaJet Presents Partner Data Demonstrating Superior Immunogenicity
27 Apr 2022 //
BUSINESSWIRE
PharmaJet Launches New Interactive Website
13 Apr 2022 //
BUSINESSWIRE
Covestro and PharmaJet work to take the sting out of vaccinations
06 Apr 2022 //
PRNEWSWIRE
PharmaJet Partner Immunomic Tx Initiates Trial of DNA Vaccine for Skin Cancer
15 Mar 2022 //
BUSINESSWIRE
PharmaJet Vaccine Delivery Featured at Sabin Vaccine Institute Conference
01 Mar 2022 //
BUSINESSWIRE
Technovalia Announces Interim Results of Needle-free COVID-19 Vaccine Trial
15 Feb 2022 //
BUSINESSWIRE
University of Cambridge Begins COVID Trial Using PharmaJet’s Needle-free System
18 Jan 2022 //
BUSINESSWIRE
PharmaJet partner Zydus Cadila Announces COVID-19 Vaccine Expansion Plan
04 Jan 2022 //
BUSINESSWIRE
Nykode Announces Phase 1/2 Trial With Next Gen DNA-Based COVID-19 Vaccines
14 Dec 2021 //
BUSINESSWIRE
PharmaJet Presents How to Improve Vaccine Performance with Needle-free Delivery
15 Nov 2021 //
BUSINESSWIRE
PharmaJet, WHO and BMGF Conduct Somalia Polio Vaccination Campaign
21 Oct 2021 //
BUSINESSWIRE
PharmaJet Presents Needle-free Delivery of COVID-19 Vaccines - Europe
12 Oct 2021 //
BUSINESSWIRE
PharmaJet selected to deliver Scancell COVID-19 DNA Vaccines
14 Sep 2021 //
BUSINESSWIRE
PharmaJet Partner Zydus Cadila Seeks EUA
07 Jul 2021 //
BUSINESSWIRE
Update: PharmaJet Needle-free COVID-19 Vaccine Trial
30 Jun 2021 //
BUSINESSWIRE
PharmaJet Announces Addition of Paul LaBarre as VP Global Business Development
15 Jun 2021 //
BUSINESSWIRE
PharmaJet and Diomics Partner on SARS-CoV-2 Immune Response Monitoring
17 Nov 2020 //
BUSINESSWIRE
